Artificial Intelligence

PathAI PathExplore™ panel will empower oncology drug developers with improved tumor microenvironment spatial characterization from H&E, propelling a new phase of precision medicine. BOSTON, April 4, 2023 /PRNewswire/ -- PathAI, a...

Nijmegen, Netherlands – Aiosyn, a medical software company that develops AI-powered pathology solutions, has been awarded a 1,6M € Eurostars grant together with Pathomation and Radboud University Medical Center to accelerate the development...

Andy Beck of PathAI: AI will continue to get better over time. Systems are continually improving and will be considerably more advanced looking ahead just five years from now. This expectation of progress gives us in the AI industry optimism...

Leica Biosystems: The BOND MMR Antibody Panel is now available for clinical use on BOND-III and BOND-MAX Immunohistochemistry (IHC) automated instruments. NEWCASTLE, UK – Leica Biosystems today announced the US Food and Drug...

PathologyWatch will use AWS Cloud solutions to advance technology capable of delivering digital pathology solutions on a global scale. SALT LAKE CITY (PRWEB) MARCH 27, 2023 - PathologyWatch today announced it has been selected to participate...

Samsung Medical Center has demonstrated the most comprehensive use of an integrated digital pathology to date. Given a rapidly aging population and an overwhelmed health system, hospitals like Samsung Medical Center had to deal with rising...